Compare · BYRN vs DHR
BYRN vs DHR
Side-by-side comparison of Byrna Technologies Inc. (BYRN) and Danaher Corporation (DHR): market cap, price performance, sector, and recent activity on the wire.
Summary
- BYRN operates in Miscellaneous, while DHR operates in Industrials - the two are in different parts of the market.
- DHR is the larger of the two at $144.26B, about 1903.3x BYRN ($75.8M).
- Over the past year, BYRN is down 84.7% and DHR is up 7.2% - DHR leads by 91.9 points.
- BYRN has been more active in the news (10 items in the past 4 weeks vs 7 for DHR).
- DHR has more recent analyst coverage (25 ratings vs 11 for BYRN).
- Company
- Byrna Technologies Inc.
- Danaher Corporation
- Price
- $3.33-2.63%
- $203.75-0.62%
- Market cap
- $75.8M
- $144.26B
- 1M return
- -41.17%
- +12.32%
- 1Y return
- -84.71%
- +7.23%
- Industry
- Industrial Machinery/Components
- Industrial Machinery/Components
- Exchange
- NASDAQ
- NYSE
- IPO
- News (4w)
- 10
- 7
- Recent ratings
- 11
- 25
Byrna Technologies Inc.
Byrna Technologies Inc., a less-lethal defense technology company, develops and manufactures less-lethal munitions. The company offers a Byrna line of handheld personal security devices, including the Byrna HD, a .68 caliber handheld personal security device that is designed to be used by civilians and private security professionals, as well as Byrna HD magazines, launchers, and projectiles. It operates in the United States, Canada, and South Africa. The company was formerly known as Security Devices International, Inc. and changed its name to Byrna Technologies Inc. in March 2020. Byrna Technologies Inc. was incorporated in 2005 and is headquartered in Andover, Massachusetts.
Danaher Corporation
Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The company operates through three segments: Life Sciences, Diagnostics, and Environmental & Applied Solutions. The Life Sciences segment provides mass spectrometers; cellular analysis, lab automation, and centrifugation instruments; microscopes; and genomics consumables. This segment also offers bioprocess technologies, consumables, and services; and filtration, separation, and purification technologies to the pharmaceutical and biopharmaceutical, food and beverage, medical, and life sciences companies, as well as universities, medical schools and research institutions, and various industrial manufacturers. The Diagnostics segment provides chemistry, immunoassay, microbiology, and automation systems, as well as hematology and molecular diagnostics products. This segment offers analytical instruments, reagents, consumables, software, and services for hospitals, physicians' offices, reference laboratories, and other critical care settings. The Environmental & Applied Solutions segment offers instrumentation, consumables, software, services, and disinfection systems to analyze, treat, and manage ultra-pure, potable, industrial, waste, ground, source, and ocean water in residential, commercial, industrial, and natural resource applications. This segment also provides instruments, software, services, and consumables for various color and appearance management, packaging design and quality management, packaging converting, printing, marking, coding, and traceability applications for consumer, pharmaceutical, and industrial products. The company was formerly known as Diversified Mortgage Investors, Inc. and changed its name to Danaher Corporation in 1984. Danaher Corporation was founded in 1969 and is headquartered in Washington, the District of Columbia.
Latest BYRN
- Chief Financial Officer Kearnes Laurilee converted options into 7,500 shares, increasing direct ownership by 80% to 16,887 units (SEC Form 4)
- Amendment: SEC Form SCHEDULE 13G/A filed by Byrna Technologies Inc.
- Byrna Technologies downgraded by Roth Capital with a new price target
- Byrna Technologies Inc. filed SEC Form 8-K: Results of Operations and Financial Condition, Financial Statements and Exhibits
- SEC Form 10-Q filed by Byrna Technologies Inc.
- Byrna Technologies Reports Fiscal Second Quarter 2026 Results
- Byrna Technologies Inc. filed SEC Form 8-K: Entry into a Material Definitive Agreement, Regulation FD Disclosure, Financial Statements and Exhibits
- Byrna Technologies Enters Definitive Agreement to Acquire HERO Defense Systems Assets
- Byrna Technologies Selects Acceleration Partners to Expand Creator Network and Relaunch Affiliate Marketing Program
- Byrna Technologies to Report Fiscal Second Quarter 2026 Financial Results on Thursday, July 9, 2026 at 9:00 a.m. ET
Latest DHR
- VP, Chief Accounting Officer Bouda Christopher covered exercise/tax liability with 60 shares, decreasing direct ownership by 0.65% to 9,107 units (SEC Form 4)
- Director Filler Linda exercised 3,298 shares at a strike of $71.88 and covered exercise/tax liability with 1,181 shares, increasing direct ownership by 9% to 26,829 units (SEC Form 4)
- Director Zerhouni Elias A. exercised 3,298 shares at a strike of $71.88 and covered exercise/tax liability with 1,181 shares, increasing direct ownership by 5% to 45,303 units (SEC Form 4)
- Audax Private Equity and Linden Capital Partners Agree to Sell StatLab Medical Products to Leica Biosystems
- Danaher Foundation Commits $1 Million to Ebola Outbreak Relief Efforts in Central Africa
- Danaher Schedules Second Quarter 2026 Earnings Conference Call
- Masimo Receives FDA 510(k) Clearance for AI-Enabled Opioid-Induced Respiratory Depression (OIRD) Detection on Radius VSM® to Help Identify Respiratory Risk Sooner
- SEC Form 11-K filed by Danaher Corporation
- Piper Sandler initiated coverage on Danaher with a new price target
- Danaher Completes Acquisition of Masimo Corporation